A Mechanistic Investigation of Risk Factors for Opioid Use Disorder: Examining Hippocampal-based Context-dependent Learning and Memory Associated With Adverse Childhood Experiences

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The way people process and remember information may be related to adverse childhood experiences and Opioid Use Disorder symptoms. The purpose of this project is to examine brain function and performance during learning and memory tasks in adults. The study will compare measures of learning and memory across three groups of participants: those with an Opioid Use Disorder (OUD) that take buprenorphine for opioid replacement therapy, adults without an Opioid Use Disorder taking buprenorphine, and healthy adults that do not have an Opioid Use Disorder and are not taking buprenorphine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:

• Right handed

• Able to give informed consent

• Normal/corrected-to-normal vision and hearing

• Diagnosis of OUD

• Be actively receiving buprenorphine (BUP) for opioid agonist therapy

• Be free from illicit substance use for at least 2 weeks

• The study will allow stable dose (\> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)

• Taking BUP for chronic pain

• No Substance Use Disorder (including OUD)

• The study will allow stable dose (\> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)

• Not taking BUP

• Free of any psychiatric or major medical conditions

Locations
United States
Michigan
University of Michigan
RECRUITING
Ann Arbor
Contact Information
Primary
Aml Almamri
AdversityBrainOUD@med.umich.edu
734-232-4166
Backup
Madeline Vincent
AdversityBrainOUD@med.umich.edu
734-232-0190
Time Frame
Start Date: 2025-01-09
Estimated Completion Date: 2028-04
Participants
Target number of participants: 315
Treatments
Other: Opioid use disorder (OUD) group
This group takes buprenorphine and has OUD.
Other: Buprenorphine (BUP) control group:
This group takes BUP and does not have OUD.
Other: Healthy Controls group
This group does not take BUP and does not have OUD.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: University of Michigan

This content was sourced from clinicaltrials.gov